How to fix our medical R&D model: A spotlight on TB treatment

IAS 2019 symposium: Expert speakers to discuss how to reform the medical research and development (R&D) model and how to foster a more effective TB response.

Read More →

Online consultation to update the Global Plan to End TB

Stop TB Partnership launches online consultation to update the Global Plan to End TB 2016-2020; Deadline for submission: 19 July 2019

Read More →

MSF technical brief: A rapid TB test for people living with HIV

TB LAM can help close the deadly TB testing gap.

Read More →

Activists demand Johnson & Johnson drop the price of bedaquiline

Activists storm the corporate stall of Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) at the 9th South African AIDS Conference.

Read More →

Advocates call on TB Alliance to make public the pretomanid licensing agreement with Mylan

Advocates request full access to the terms of the agreement granting Mylan the rights to commercialize pretomanid.

Read More →

FDA Antimicrobial Drugs Advisory Committee recommends approval of pretomanid

Investigational drug pretomanid is under regulatory review by FDA for treatment of XDR-TB and treatment-intolerant or non-responsive MDR-TB as part of a new investigational regimen.

Read More →

Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

Read More →

WHO launches multisectoral accountability framework to end TB

WHO launches a multisectoral accountability framework to end TB as requested by the World Health Assembly and the UN General Assembly in 2018.

Read More →

Declaration of the Rights of People Affected by TB launched

The launch of the Declaration is a significant step in recognizing the urgent need to adopt a human rights-based approach to TB and fund human rights-based interventions that overcome barriers to universal access.

Read More →

Community capacity building modules to accelerate DR-TB response

Community capacity building modules to accelerate the response to drug-resistant TB launched at WHO meeting of national TB program managers and partners in the South-East Asia region.

Read More →

Page 1 of 98 · Total posts: 10

1 2 Last→